Firmino F. Rubaltelli
Research Subjects
Research Interests
Firmino F. Rubaltelli has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- C. Dani
Department of Pediatrics - Division of Neonatology, Careggi University Hospital of Florence, Florence
8 shared publications - Giovanna Bertini
Division of Neonatology, Careggi University Hospital of Florence, 50134 Florence, Italy
5 shared publications G Bertini
Department of Pediatrics - Division of Neonatology, Careggi University Hospital of Florence, Florence
4 shared publicationsM F Reali
Department of Pediatrics - Division of Neonatology, Careggi University Hospital of Florence, Florence
4 shared publications- M Pezzati
DEPARTMENT OF SURGICAL AND MEDICAL CRITICAL CARE, SECTION OF NEONATOLOGY, Italy
3 shared publications - Carlo Dani
Department of Neurosciences, Psychology, Drug Research and Child Health, University of Florence, 50134 Florence, Italy
2 shared publications
Latest Publications
- 1 August 2005
- Published by Springer Nature in Pediatric Research
- Vol. 58 (2) , 373
107 Comparison of Oral and Intravenous Ibuprofen Treatment of PDA in VLBW Infants: A Randomized Clinical Trial
- 1 August 2005
- Published by Springer Nature in Pediatric Research
- Vol. 58 (2) , 373
107 Comparison of Oral and Intravenous Ibuprofen Treatment of PDA in VLBW Infants: A Randomized Clinical Trial
- 1 August 2005
- Published by Springer Nature in Pediatric Research
- Vol. 58 (2) , 367
77 Inhaled Nitric Oxide in Preterm Infants of less than 30 Weeks' Gestation with Respiratory Distress Syndrome
- 1 August 2005
- Published by Springer Nature in Pediatric Research
- Vol. 58 (2) , 367
77 Inhaled Nitric Oxide in Preterm Infants of less than 30 Weeks' Gestation with Respiratory Distress Syndrome
- 1 September 2004
- Published by Springer Nature in Pediatric Research
- Vol. 56 (3) , 473
57 Prophylactic Ibuprofen for The Prevention of Intraventricular Hemorrhage in Preterm Infants: A Multicenter Randomized Study
- 1 September 2004
- Published by Springer Nature in Pediatric Research
- Vol. 56 (3) , 473
57 Prophylactic Ibuprofen for The Prevention of Intraventricular Hemorrhage in Preterm Infants: A Multicenter Randomized Study
- 1 January 2002
- Vol. 28 (5) , 207-10
Pharmacokinetics of oxatomide in preterm infants.
The pharmacokinetics and tolerability of oxatomide oral suspension were investigated in preterm infants to evaluate the feasibility of planning a further study to assess its antiinflammatory effects and its effectiveness in preventing chronic lung disease (CLD). Following the administration of oxatomide 1 mg/kg, the peak plasma concentration (Cmax), the elimination half-life (t1/2), the volume of distribution (Vd), and the area under the curve (AUC) 0-36 h were measured and the following results were obtained: 42.2 +/- 15 ng/ml at 2 h after oxatomide administration, 41.4 +/- 2.0 h, 37.4 +/- 4.2 l/kg, and 468 +/- 52 ng/ml/h, respectively. Our study, therefore, demonstrated that a dose of 1 mg/kg/day oxatomide was effective in reaching therapeutic plasma levels in preterm infants without inducing adverse effects.
- 1 January 2002
- Vol. 28 (5) , 207-10
Pharmacokinetics of oxatomide in preterm infants.
The pharmacokinetics and tolerability of oxatomide oral suspension were investigated in preterm infants to evaluate the feasibility of planning a further study to assess its antiinflammatory effects and its effectiveness in preventing chronic lung disease (CLD). Following the administration of oxatomide 1 mg/kg, the peak plasma concentration (Cmax), the elimination half-life (t1/2), the volume of distribution (Vd), and the area under the curve (AUC) 0-36 h were measured and the following results were obtained: 42.2 +/- 15 ng/ml at 2 h after oxatomide administration, 41.4 +/- 2.0 h, 37.4 +/- 4.2 l/kg, and 468 +/- 52 ng/ml/h, respectively. Our study, therefore, demonstrated that a dose of 1 mg/kg/day oxatomide was effective in reaching therapeutic plasma levels in preterm infants without inducing adverse effects.
- 1 January 2000
- Vol. 71
[Prophylaxis of group B beta-hemolytic streptococcal infections].
Group B streptococcus is a possible cause of chorioamnionitis, endometritis and urinary tract infections in pregnant woman. Maternal risk factors and the vertical transmission of GBS and neonatal GBS infection occur through the following fever during labor, the rupturing of membranes more than 18 hours before delivery, prematurity and chorioamnionitis. GBS can induce early-onset neonatal disease (sepsis, meningitis or pneumonia) during the first week of life and late-onset neonatal infection (leptomeningitis) within the first 12 weeks of life. Numerous strategies for preventing neonatal group B streptococcal infection were investigated: 1) the treatment of GBS-colonized women during the third trimester of pregnancy did not prove to be effective because it does not reduce maternal colonizzation rates at delivery; 2) the neonatal universal post-partum prophylaxis with penicillin G was ineffective and increased neonatal mortality due to penicillin-resistant bacterial infection; 3) the intrapartum maternal chemoprophylaxis with penicillin G or ampicillin in GBS-colonized women, in women with risk factors, or in women with both GBS colonization and risk factors. The latter strategy proved to be the most effective because it reduces the risk of early-onset GBS infection by 75% and 95% when associated with post-neonatal prophylaxis. To date, there are no guidelines on the management of the asymptomatic neonate whose mothers have been treated with chemopropylaxis intra-partum.
- 1 January 2000
- Vol. 71
[Prophylaxis of group B beta-hemolytic streptococcal infections].
Group B streptococcus is a possible cause of chorioamnionitis, endometritis and urinary tract infections in pregnant woman. Maternal risk factors and the vertical transmission of GBS and neonatal GBS infection occur through the following fever during labor, the rupturing of membranes more than 18 hours before delivery, prematurity and chorioamnionitis. GBS can induce early-onset neonatal disease (sepsis, meningitis or pneumonia) during the first week of life and late-onset neonatal infection (leptomeningitis) within the first 12 weeks of life. Numerous strategies for preventing neonatal group B streptococcal infection were investigated: 1) the treatment of GBS-colonized women during the third trimester of pregnancy did not prove to be effective because it does not reduce maternal colonizzation rates at delivery; 2) the neonatal universal post-partum prophylaxis with penicillin G was ineffective and increased neonatal mortality due to penicillin-resistant bacterial infection; 3) the intrapartum maternal chemoprophylaxis with penicillin G or ampicillin in GBS-colonized women, in women with risk factors, or in women with both GBS colonization and risk factors. The latter strategy proved to be the most effective because it reduces the risk of early-onset GBS infection by 75% and 95% when associated with post-neonatal prophylaxis. To date, there are no guidelines on the management of the asymptomatic neonate whose mothers have been treated with chemopropylaxis intra-partum.
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 193A
Retinopathy of Prematurity in Infants with Birthweight Lower Than 1250 Grams: Role of Blood Transfusion, Iron and Erythropoietin Treatment
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 193A
Retinopathy of Prematurity in Infants with Birthweight Lower Than 1250 Grams: Role of Blood Transfusion, Iron and Erythropoietin Treatment
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 192A
Effects of Application of Vitamin E Ointment to Premature Neonates' Skin: Preliminary Data
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 192A
Effects of Application of Vitamin E Ointment to Premature Neonates' Skin: Preliminary Data
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 192A
Brain Hemodynamic Changes in Preterm Infants after Caffeine and Theophylline Treatment
- 1 April 1999
- Published by Springer Nature in Pediatric Research
- Vol. 45 (4, Part 2 ) , 192A
Brain Hemodynamic Changes in Preterm Infants after Caffeine and Theophylline Treatment
- 5 June 1998
- Published by S. Karger AG in Neonatology
- Vol. 74 (1) , 7-15
Epidemiology of Neonatal Acute Respiratory Disorders
A prospective 3-month survey of neonatal respiratory disorders in 17,192 Italian infants born in 65 hospitals, located in 17 Italian regions representative of northern, central and southern Italy, was performed to evaluate the incidence of neonatal acute respiratory disorders and their risk factors. The prematurity rate was 7.3%, while the extremely low birth weight (<1,000 g) and very low birth weight (<1,500 g) rates were 0.58% and 0.99%, respectively. Four hundred and ninety-one infants (2.8%) developed respiratory signs. Lethality or specific fatality rate (SFR) for acute respiratory disorders with regard to the overall study population was 0.45%. The male/female ratio of affected infants was 1.3:1. Among affected newborns the case fatality rate (CFR) for respiratory disorders was 15.88% (78/491) and was higher in males than in females (2:1), in infants with a gestational age of ≤28 weeks (60%) and birth weights of <1,000 g (50%). Moreover, the SFR was higher (p < 0.05) in the infants of mothers older than 34 years. SFR was 3.0% in intrauterine growth-retarded infants, 3.6% in the first twin and 3.2% in the second twin. An Apgar score of ≤3 at 5 min was strongly related to the incidence of respiratory disorders (47.1%). The antenatal prevention of neonatal respiratory distress syndrome with maternal corticosteroid treatment was performed in 84% of newborns (34 years are risk factors for acute respiratory disorders.
- 5 June 1998
- Published by S. Karger AG in Neonatology
- Vol. 74 (1) , 7-15
Epidemiology of Neonatal Acute Respiratory Disorders
A prospective 3-month survey of neonatal respiratory disorders in 17,192 Italian infants born in 65 hospitals, located in 17 Italian regions representative of northern, central and southern Italy, was performed to evaluate the incidence of neonatal acute respiratory disorders and their risk factors. The prematurity rate was 7.3%, while the extremely low birth weight (<1,000 g) and very low birth weight (<1,500 g) rates were 0.58% and 0.99%, respectively. Four hundred and ninety-one infants (2.8%) developed respiratory signs. Lethality or specific fatality rate (SFR) for acute respiratory disorders with regard to the overall study population was 0.45%. The male/female ratio of affected infants was 1.3:1. Among affected newborns the case fatality rate (CFR) for respiratory disorders was 15.88% (78/491) and was higher in males than in females (2:1), in infants with a gestational age of ≤28 weeks (60%) and birth weights of <1,000 g (50%). Moreover, the SFR was higher (p < 0.05) in the infants of mothers older than 34 years. SFR was 3.0% in intrauterine growth-retarded infants, 3.6% in the first twin and 3.2% in the second twin. An Apgar score of ≤3 at 5 min was strongly related to the incidence of respiratory disorders (47.1%). The antenatal prevention of neonatal respiratory distress syndrome with maternal corticosteroid treatment was performed in 84% of newborns (34 years are risk factors for acute respiratory disorders.
- 1 April 1998
- Published by Springer Nature in Pediatric Research
- Vol. 43 (4) , 296
Does early closure of PDA with ibuprofen reduce the severity of RDS in premature infants? † 1736
- 1 April 1998
- Published by Springer Nature in Pediatric Research
- Vol. 43 (4) , 296
Does early closure of PDA with ibuprofen reduce the severity of RDS in premature infants? † 1736